Day Time Activity Level in Inpatient Neurological Rehabilitation as Related to Functional Outcomes at Discharge, Length of Stay, Discharge Location, and Quality of Life: a Preliminary Study
Day-time Activity Level In Inpatient Neurological Rehabilitation as Related to Functional Outcomes at Discharge, Length of Stay, Discharge Location, and Quality of Life: A Preliminary Study
1 other identifier
observational
60
1 country
1
Brief Summary
This preliminary study is intended to collect activity level data in a preliminary longitudinal means in order to gain more knowledge into our patient's current activity status. Our long-term objective of tracking patient activity levels in relation to function and length of stay is to identify opportunities for improved patient activity level, decreased length of stay, and increased functional mobility at discharge. The main purpose of this study is the exploration of the ability to generate meaningful activity data. Usual standard of care will be taking place during this preliminary study, there is not an intervention being studied at this time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 26, 2018
CompletedFirst Submitted
Initial submission to the registry
January 23, 2019
CompletedFirst Posted
Study publicly available on registry
August 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 23, 2020
CompletedApril 5, 2021
April 1, 2021
1.8 years
January 23, 2019
April 1, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Sedentary Minutes
Sedentary minutes will be reported from the Fitbit Charge 2.
Length of stay in the inpatient facility-will differ for each patient (expected average of 3 weeks)
Lightly Active Minutes
Lightly active minutes will be reported from the Fitbit Charge 2.
Length of stay in the inpatient facility-will differ for each patient (expected average of 3 weeks)
Fairly Active Minutes
Fairly active minutes will be reported from the Fitbit Charge 2.
Length of stay in the inpatient facility-will differ for each patient (expected average of 3 weeks)
Very Active Minutes
Very active minutes will be reported from the Fitbit Charge 2.
Length of stay in the inpatient facility-will differ for each patient (expected average of 3 weeks)
Minutes Asleep
Minutes asleep will be reported from the Fitbit Charge 2.
Length of stay in the inpatient facility-will differ for each patient (expected average of 3 weeks)
Secondary Outcomes (1)
Cognitive Function via the FIM Instrument
Length of stay in the inpatient facility-will differ for each patient (expected average of 3 weeks)
Study Arms (1)
Level of Activity
Level of activity for all patients admitting to the inpatient neurological rehabilitation unit.
Interventions
Inpatients will be asked if they are willing to wear a heart rate tracking fitness watch during their stay. They will be asked quality of life questions on a questionnaire that will take approximately 30 minutes to answer at admission and discharge. At the end of the study they will return the Fitbit Charge 2 to the study coordinator or their nurse. Your rehabilitation plan of care will not change in any other way.
Eligibility Criteria
Patients admitting to the Inpatient Neurological Specialty Unit (a rehab unit)
You may qualify if:
- English as a first speaking language
- willingness to participate (family consent if patient is not able to consent)
- ability to wear a heart rate tracking device during full admission
- intact skin integrity of the arms
- commercial insurance or government insurance (medicare or medicaid)
- an estimated length of stay greater than 5 days and less than 5 weeks at initial assessment by the admitting team
You may not qualify if:
- patients with multiple sclerosis (MS), brain tumors, or degenerative neurological disorders
- patients with a pacemaker, left ventricular assist device, or with ventilator support
- patients without health insurance in place
- non-primary English speaking
- patients who require 1:1 supervision as they are deemed unable to comply with device wearing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Intermountain Medical Center
Salt Lake City, Utah, 84107, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kelli Cooper, PT, DPT, NCS
Intermountain Health Care, Inc.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2019
First Posted
August 22, 2019
Study Start
November 26, 2018
Primary Completion
September 23, 2020
Study Completion
September 23, 2020
Last Updated
April 5, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share